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Marine microalgae are considered a potentially new and valuable source of biologically
active molecules for applications in the food industry as well as in the pharmaceutical,
nutraceutical, and cosmetic sectors. They can be easily cultured, have short
generation times and enable an environmentally-friendly approach to drug discovery
by overcoming problems associated with the over-utilization of marine resources and
the use of destructive collection practices. In this study, 21 diatoms, 7 dinoflagellates,
and 4 flagellate species were grown in three different culturing conditions and
the corresponding extracts were tested for possible antioxidant, anti-inflammatory,
anticancer, anti-diabetes, antibacterial, and anti-biofilm activities. In addition, for three
diatoms we also tested two different clones to disclose diversity in clone bioactivity.
Six diatom species displayed specific anti-inflammatory, anticancer (blocking human
melanoma cell proliferation), and anti-biofilm (against the bacteria Staphylococcus
epidermidis) activities whereas, none of the other microalgae were bioactive against
the conditions tested for. Furthermore, none of the 6 diatom species tested were toxic
on normal human cells. Culturing conditions (i.e., nutrient starvation conditions) greatly
influenced bioactivity of the majority of the clones/species tested. This study denotes
the potential of diatoms as sources of promising bioactives for the treatment of human
pathologies.
Keywords: drug discovery, marine biotechnology, nutrient starvation, clones, diatoms, anti-inflammatory,
anticancer, anti-biofilm
INTRODUCTION
Cancer, inflammation, and the evolution of antibiotic-resistant pathologies, together with other
human diseases, are continuously stimulating the search for new bioactive molecules from natural
sources. Unlike drug discovery on land, marine drug discovery is a relatively new field which
began in the 1940s with the advent of scuba diving and new sampling technologies that allowed
scientists to systematically probe the oceans for useful therapeutics. The number of potential
compounds isolated frommarine organisms now exceeds 28,000 with hundreds of new compounds
being discovered every year (Blunt et al., 2015). However, despite the number of compounds
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isolated from marine organisms and the biological activities
attributed to many of these, those that have either been marketed
or are under development are relatively few (Jaspars et al., 2016).
To date, the global marine pharmaceutical pipeline consists
of seven approved pharmaceuticals in clinical use, four of
which are anticancer drugs, and about 26 natural products in
Phase I to Phase III clinical trials, 23 as anticancer agents, two
for schizophrenia and Alzheimer’s, and one for chronic pain
(http://marinepharmacology.midwestern.edu/clinPipeline.htm).
Most of these natural products have been isolated from
Porifera (sponges) and Chordata (including ascidians) but
these macroorganisms are often difficult to cultivate and
there may be problems to obtain a sustainable supply of the
compounds of interest without ecologically impacting natural
populations. More recently, there is great interest in exploring the
biotechnological potential of microorganisms such as microalgae
since they are easier to cultivate, have short generation times
and represent a renewable and still poorly explored resource for
drug discovery. However, although a range of pharmacological
activities have been observed from microalgal extracts, the active
principles are often unknown (Mimouni et al., 2012; Guedes
et al., 2013; Nigjeh et al., 2013; Samarakoon et al., 2013).
Microalgae are photosynthetic eukaryotes that constitute
one of the major components of marine and freshwater
phytoplankton; they are primary producers, a food source for
other marine organisms, and are also excellent sources/producers
of pigments, lipids, carotenoids, ω-3 fatty acids and other fine
chemicals (Mimouni et al., 2012). Their long evolutionary and
adaptive diversification to a multitude of habitats and extreme
conditions (e.g., cold/hot environments, hydrothermal vents)
make them good candidates for drug discovery, because they
may have evolved compounds for communication, defense and
survival that are often unique and may not have any terrestrial
counterparts (Landsberg, 2002, Wolfe et al., 2002, Caldwell,
2009). Diatoms are one of the most important groups of
microalgae with over 100,000 species that occur in virtually
every environment that contains water, including not only
oceans and lakes, but also soil. Diatoms have already found
important applications as biofuels, health foods, biomolecules,
materials relevant to nanotechnology, and as bioremediators
of contaminated water (Bozarth et al., 2009). However not
much is known on the potential applications of diatoms
as pharmaceuticals. Various studies have shown that some
diatoms are rich in bioactive compounds such as the sulfated
polysaccharide named naviculan isolated from Navicula directa,
with antiviral activity (Lee et al., 2006), adenosine from
Phaeodactylum tricornutum, an antiarrhythmic agent to treat
tachycardia (Prestegard et al., 2009, 2014), and marennine,
a blue pigment identified in the marine diatom Haslea
ostrearia that has shown allelopathic, antioxidant, antibacterial,
antiviral, and growth-inhibiting properties (Gastineau et al.,
2014). Other studies have shown that the marine carotenoid
fucoxanthin found in brown seaweeds and several diatom
species has antioxidant, anti-inflammatory, anticancer, anti-
obese, antidiabetic, antiangiogenic, and antimalarial activities
(Peng et al., 2011), and that the fatty alcohol ester nonyl 8-
acetoxy-6-methyloctanoate (NAMO), isolated from the diatom
P. tricornutum, has anticancer effects on three different cancer
cell lines including human leukemia (HL-60) and lung carcinoma
(A549), and a mouse melanoma (B16F10; Samarakoon et al.,
2014). In addition to these, diatom unsaturated aldehydes
such as decadienal, octadienal, and heptadienal isolated from
Skeletonema marinoi have shown anticancer effects in lung
cancer A549 and colon COLO 205 tumor cells, without affecting
the viability of normal cells from the same tissue type (Sansone
et al., 2014).
In addition to diatoms, other microalgae (e.g., green
algae, flagellates, and dinoflagellates) have been screened for
possible biotechnological applications (MacKinnon et al., 2006;
Kobayashi, 2008; Samarakoon et al., 2013; Blunt et al.,
2015). Digalactosyldiacylglycerols and other monogalactosyl
analogs isolated from the green algae Nannochloropsis granulata
exhibited strong NO inhibitory activity against LPS-induced
NO production in RAW264.7 macrophage cells suggesting
a strong anti-inflammatory potential (Blunt et al., 2015).
Samarakoon et al. (2013) evaluated the anti-inflammatory
activity of two species of green algae, Chlorella ovalis and
Nannchloropsis oculata, and one species of dinoflagellates,
Amphidinium carterae. Even if all the species showed activity, N.
oculata hexane and chloroform fractions showed the strongest
anti-inflammatory activity. The green alga C. ovalis and the
dinoflagellate A. carterae suppressed the growth of HL-60 cells
(human promyelocytic leukemia cell line; Samarakoon et al.,
2013) also demonstrating anticancer properties.
On dinoflagellates, there are also various studies reporting
functional-based metagenomic approaches (as reviewed by
Kellmann et al., 2010). Given the fact that polyketides are
an important class of bioactive secondary metabolites, major
efforts have been focused on isolating polyketide synthase (PKS)
genes and new polyketides. PKSs have been found in several
microalge, such as Chlamydomonas reinhardtii, Ostreococcus
spp., Emiliania huxleyi, Karenia brevis, Ostreopsis cf. ovata,
Coolia monotis, Prorocentrum lima, Gymnodinium catenatum,
Heterocapsa triqueta, Azadinium spinosum, and Alexandrium
ostenfeldii (Eicholz et al., 2012; Van Dolah et al., 2013; Meyer
et al., 2015). PKSs very often synthetize potent toxins in
microalgae responsible for harmful algal blooms (HABs; Meyer
et al., 2015), impacting humans through consumption of
contaminated shellfish, finfish, and through water or aerosol
exposure. The synthesized polyketides can exert a variety of
functions, such as antipredator and allelopathic effects (Kohli
et al., 2016), but also have anticancer activity (Kobayashi, 2008)
and/or beneficial effects for the treatment of Alzheimer’s disease
(MacKinnon et al., 2006).
Not much else is known on the biotechnological potential
of microalgae as pharmaceutical agents. Few species have been
screened for their biological activity and information on how
culturing conditions affect bioactivity is almost totally lacking.
In this study, we screened crude extracts of 32 microalgal
species (21 diatoms, 7 dinoflagellates and 4 flagellates) grown
in three different culturing conditions (i.e., normal medium,
nitrogen-, and phosphate-starvation) for possible antioxidant,
anti-inflammation, anticancer, anti-diabetes, antibacterial, and
anti-biofilm activities. Oxidative stress is a major cause of
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inflammatory events implicated in a large number of diseases
(e.g., cancer, diabetes, neurodegenerative, and cardio-vascular
diseases). The main oxidative stress effectors are reactive
intermediates and free radicals such as peroxynitrite, superoxide
anion, hydroxyl, and nitric oxide radicals (Lauritano et al.,
2012). In low quantities, these are rapidly converted to
less reactive forms, but, when present in abnormally high
quantities, these free radicals can be very damaging to DNA,
RNA, and proteins. We evaluated the antioxidant potential
of microalgae using two different assays, the Cellular Lipid
Peroxidation Antioxidant Activity (CLPAA) and the Cellular
Antioxidant Activity (CAA) Assays. Oxidative stress is thought
to be an important contributing factor in the development
of inflammation and cancer. In this study, microalgal anti-
inflammatory activity was screened by evaluating the capability
to inhibit the release of tumor necrosis factor α (TNFα), one of
the main effectors of inflammation (Newton and Dixit, 2012),
in lipopolysaccharide (LPS)-stimulated monocytic leukemia cells
(THP-1). Anticancer properties were evaluated by testing the
antiproliferative activity against human melanoma cells (A2058).
Melanoma is a neoplastic disorder of melanocytes, occurring
in the skin and in the soft tissue of the meninges, mucous
membranes, and upper esophagus (Bajetta et al., 2002). The
incidence of melanoma is increasing rapidly, especially in the US
and Europe, particularly in young adults, mainly due to UV over
exposure (Bajetta et al., 2002). In order to discriminate between
toxicity and specific anticancer activity, extracts were also tested
for toxicity on human fetal lung cells (MRC-5).
We also evaluated the capability of extracts to inhibit the
protein tyrosine phosphatase 1B, a negative regulator of insulin
receptor signal transduction and a drug target for the treatment
of type 2- diabetes (Gum et al., 2003).There is increasing evidence
in both experimental and clinical studies suggesting that Type 2-
diabetes is a long-term metabolic disorder that is characterized
by high blood sugar, insulin resistance, and relative lack of
insulin. Common long-term complications from high blood
sugar include heart disease, strokes, diabetic retinopathy which
can result in blindness, kidney failure, and poor blood flow in the
limbs.
Another important and common threat for human health
is characterized by bacterial infections. We therefore also
performed two different antibacterial assays: minimum
inhibitory concentration (MIC) assay, to evaluate if the
extracts were able to inhibit the growth of various Gram-
negative (Escherichia coli and Pseudomonas aeruginosa) and
Gram-positive (Staphylococcus aureus, Enterococcus faecalis,
and Streptococcus B) bacteria, and the anti-biofilm assay
to check activity against biofilm formation by the bacteria
Staphylococcus epidermidis. S. epidermidis is responsible
for common hospital-acquired infections (Levinson, 2010)
and is of particular concern for people with catheters or
other surgical implants (Salyers and Whitt, 2002). The aim
of this study was therefore to give a broad overview of
microalgal activities, including the testing of different clones
and culturing conditions, and to look for promising sources of
biologically activemolecules for the treatment of different human
diseases.
MATERIALS AND METHODS
Microalgae Culturing and Maintenance
Microalgae (32 species), previously identified by microscopy and
18S sequencing, were selected from the Stazione Zoologica Anton
Dohrn culture collection for culturing and activity screening
(Table 1). 21 diatoms, 7 dinoflagellates, and 4 flagellates were
selected from those that have previously been shown to have
anti-grazing and anti-proliferative activities on their predators
at sea (Ianora and Miralto, 2010) or species responsible for
toxic blooms worldwide (Gorbi et al., 2013, Sampedro et al.,
2013). Diatoms and flagellates were grown in Guillard’s f/2
medium (Guillard, 1975; For flagellates f/2 without silicates) and
dinoflagellates in Keller medium (Keller et al., 1987) in 10 L
polycarbonate bottles. Species were grown in normal, nitrogen-
and/or phosphate- starved media (90 µM NO3− for N-starved
and 0.5 µM PO2−4 for P-starved media). Cultures were kept in a
climate chamber at 19◦C at a 12:12 h light:dark cycle at 100 µmol
photons m−2 s−1. Initial cell concentrations were about 50,000
cells/mL for each experiment and at the end of the stationary
phase, cultures were centrifuged for 30min at 4◦C at 3900 g and
pellets (for the approximate pellet weight and cell concentration
used for the chemical extractions of microalgae cultured in
control, nitrogen- and phosphate-starvation see Table 1) and
kept at−80◦C until chemical extraction.
Chemical Extraction and Pre-Fractionation
Fifty millilitre of distilled water was added to the microalgal
pellets and samples were sonicated for 1 min at maximum
intensity. The same volume of acetone was added and, after
50 min mixing at room temperature, samples were evaporated
under nitrogen stream down to half of their volume. In order
to start fractionation of the samples we used Amberlite R©
XAD16N resin that is a macroreticular, styrene-divinylbenzene
copolymer, nonionic bead (Sigma-Aldrich). The hydrophobic
chemical nature of the resin makes the XAD16N an excellent
adsorbent under reversed phase conditions, to bind non-polar
solute from water. Only the extracts adsorbed and successively
released from the resin were investigated in this study. In detail,
about 1 g of Amberlite XAD16N resin (20–60 mesh, Sigma-
Aldrich) was added to each sample. After 50min of mixing at
room temperature, samples were centrifuged (15min at 3500 g
at room temperature) and 18mL of water were added to the resin
for a washing step. After 50min of mixing at room temperature,
a centrifugation step (15min at 3500 g at room temperature)
allowed the elimination of water and the resin was incubated
with 10ml acetone for 50min. Centrifugation (at 3500 g) for
15min at room temperature allowed the resin to settle and the
supernatants, that were the final extracts, were freeze-dried and
stored at −20◦C until screening. Before performing the assays,
extracts were first diluted at 1mg/mL withMilliQ water and 2.5%
DMSO. A triplicate of control plus the same concentration of
DMSO found in test wells was used in all assays.
Cytotoxicity Assay
Cytotoxicity was evaluated after 24 h exposure in human
hepatocellular liver carcinoma (HepG2, ATCC HB-8065TM)
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TABLE 1 | The table reports the culture collection code, species name, and class, medium (M) used for culturing, axenicity (Ax) information, and sampling
location for each microalgae selected for this study. In addition, it reports the approximate pellet weight (PW) and cell concentration used for the
chemical extractions of microalgae cultured in control, nitrogen- and phosphate-starvation (C, N, and P, respectively).
Species name Class M Ax Sampling Location PW in C, N, and P Cell conc in C, N, and P
FE2 Cylindrotheca closterium Bacillariophyceae F/2 Mediterra nean Sea 5; 4; 4 4 × 105; 2 × 105; 2 × 105
FE300 Coscinodiscus actinocyclus Bacillariophyceae F/2 Mediterra nean Sea 7; 4; 4 2 × 105; 104; 5 × 105
FE321 Nitzschia closterium Bacillariophyceae F/2 Mediterra nean Sea 2,3; 1,5; 1,5 106; 105; 105
MC1098_1 Pseudo-nitzschia pseudodelicatissima Bacillariophyceae F/2 Mediterra nean Sea 3,4; 3; 2,3 3 × 105; 105; 105
MC1098_2 Pseudo-nitzschia pseudodelicatissima Bacillariophyceae F/2 Mediterra nean Sea 4; 3; 3 4 × 105; 105; 105
FE205 Tetraselmis suecica Chlorodendrophycea e F/2 x Atlantic Ocean 5,6; 4; 5 106; 105; 105
FE207 Isochrysis galbana Coccolithophyceae F/2 x Atlantic Ocean 2,4; 1; 0,9 106; 105; 105
FE25 Skeletonema costatum Coscinodiscophyceae F/2 Mediterranean Sea 6; 4; 4 106; 105; 105
FE315 Lauderia annulata Coscinodiscophyceae F/2 Mediterranean Sea 5,5; 5; 3,2 8 × 104; 4 × 104; 4 × 104
FE322 Leptocylindrus danicus Coscinodiscophyceae F/2 Mediterranean Sea 2; 1,6; 1,4 8 × 104; 104; 103
FE324 Chaetoceros affinis Coscinodiscophyceae F/2 Mediterranean Sea 5; 4; 4 105; 104; 104
FE326 Odontella mobiliensis Coscinodiscophyceae F/2 Mediterranean Sea 4,2; 1,1; 1 105; 104; 104
FE332 Leptocylindrus aporus Coscinodiscophyceae F/2 Mediterranean Sea 7; 2,3; 3,7 8 × 105; 104; 104
FE4 Thalassiosira rotula Coscinodiscophyceae F/2 x Mediterranean Sea 3; 2; 2 106; 105; 105
FE5 Thalassiosira weissflogii Coscinodiscophyceae F/2 x Atlantic Ocean 6; 3; 3 106; 105; 105
FE6 Skeletonema marinoi Coscinodiscophyceae F/2 x Mediterranean Sea 5,6; 2; 1,5 106; 105; 105
FE60 Skeletonema marinoi Coscinodiscophyceae F/2 Mediterranean Sea 5,8; 4; 1,8 106; 105; 105
FE80 Thalassiosira rotula Coscinodiscophyceae F/2 Mediterranean Sea 6; 4; 4 106; 105; 105
FE85 Skeletonema costatum Coscinodiscophyceae F/2 x Mediterranean Sea 6; 3; 3 106; 105; 105
FE96 Stephanopyxis turris Coscinodiscophyceae F/2 Atlantic Ocean 3; 2; 2 104; 103; 103
L1 Bacteriastrum hyalinum Coscinodiscophyceae F/2 Mediterranean Sea 5; 4; 4 105; 104; 104
L2 Guinardia striata Coscinodiscophyceae F/2 Mediterranean Sea 7; 5; 5 105; 104; 104
L4 Proboscia alata Coscinodiscophyceae F/2 Mediterranean Sea 6; 5; 4,2 105; 104; 104
FE118 Guillardia theta Cryptophyceae K x Atlantic Ocean 4; 2,5; 2,5 104; 103; 103
FE202 Rhodomonas baltica Cryptophyceae F/2 Mediterranean Sea 3,8; 1,5; 1 5 × 105; 104; 104
FE208 Rhinomonas reticulata Cryptophyceae F/2 x Mediterranean Sea 4; 2,4; 4 105; 104; 104
FE107 Alexandrium tamutum Dinophyceae K Mediterranean Sea 1,6; 0,8; 0,8 2 × 104; 6 × 103; 103
FE108 Alexandrium andersonii Dinophyceae K Mediterranean Sea 1; 0,8; 0,8 2 × 104; 5 × 103; 2 × 103
FE119 Ostreopsis ovata Dinophyceae K Mediterranean Sea 1; 0,8; 0,8 4 × 103; 103; 103
FE126 Alexandrium minutum Dinophyceae K Mediterranean Sea 2,3; 1; 1 105; 104; 104
L3 Lepidodinium viride Dinophyceae F/2 Mediterranean Sea 5; 3,5; 2,3 104; 5 × 103; 103
MC1098_3 Prorocentrum gracile Dinophyceae K Mediterranean Sea 3; 2,5; 2,5 105; 104; 104
and 72 h exposure in normal human lung fibroblast (MRC-5,
ATCC CCL-171TM) cells. For the 24 h study, 20,000 HepG2
cells were seeded per well. For the 72 h study, 6000 MRC-
5 cells were used. HepG2 and MRC5 were grown overnight,
and then incubated with 50 µg/mL test extract diluted in
MEM Earle’s supplemented with gentamycin (10 µg/mL), non-
essential amino acids (1%), sodium pyruvate (1mM), L-alanyl-
L-glutamine (2mM), but without FBS (total volume was 100
µl). Ten µL of CellTiter 96 R© AQueous One Solution Reagent
(Promega, Madison, WI, USA) was added and plates were then
further incubated for 1 h. Absorbance was measured at 485 nm
in a DTX 880 Multimode Detector. Results were calculated as %
survival compared to negative (assay media) and positive (Triton
X-100; Sigma-Aldrich) controls. The screening was performed
using 2–3 biological replicates and 6–9 technical replicates (i.e.,
duplicate/triplicate chemical extractions from each microalgae).
Cellular Lipid Peroxidation Antioxidant
Activity (CLPAA) Assay
Approximately 90,000 HepG2 cells per well (100µl final volume)
were seeded in black 96 well-plates with clear bottoms (Corning,
NY, USA) with MEM Earle’s medium (F0325) and incubated at
37◦C with 5% CO2 overnight (Pap et al., 1999; Lind et al., 2013).
Briefly, cells were labeled with 5 µM C11-BODIPY (#D3861,
Invitrogen, Eugene, OR, USA) for 30min and incubated for 1 h
with 50µg/mL test extracts. Cumene hydroperoxide (CumOOH,
Sigma-Aldrich; final concentration 50 µM) was added to initiate
lipid peroxidation and the plate was immediately installed
in a Victor3 Plate Reader. Both red (590/632 nm) and green
(485/520 nm) fluorescence were recorded. Cells in Hanks buffer
were used as negative control and cells treated with CumOOH as
positive control. The screening was performed using at least two
biological replicates.
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Antioxidant Assay for Cellular Antioxidant
Activity (CAA)
The CAA assay was performed as in Lind et al. (2013). Briefly,
HepG2 80,000 cells/well were seeded in black 96-well-plates
(#3603, Corning, NY, USA) and incubated with 25 µM DCFH-
DA (2′7′-dichlorofluorescin diacetate; Fluka, 35847) and the
test extracts (50 µg/mL) in duplicate for 1 h. Luteolin (final
concentration of 50 µg/mL) was used as antioxidant control.
After incubation, Hank’s saline solution without phenol red
(Biochrom, BCHRL2035) supplemented with 2,2-azobis (2-
amidinopropane) dihydrochloride AAPH (600 µM) was added
to all the wells, except for the negative control (without AAPH).
Fluorescence was recorded in a Victor3 Plate Reader (485 nm).
The screening was performed using at least two biological
replicates.
Anti-Inflammatory Assay
The assay was performed as in Lind et al. (2013). Briefly, ∼106
human monocyte (acute monocytic leukemia) THP-1 cells/mL
(ATCC TIB-202) supplemented with 50 ng/mL phorbol 12-
myristate 13-acetate (PMA, Sigma Aldrich) were seeded in 96
well plates and incubated at 37◦C, 5%CO2 for 48 h in RPMI-1640
medium (Biochrom; 10% FBS). After 72 h, 80 µL fresh RPMI
medium and 10 µL/well (tested concentration 100 µg/mL) of
test extract were added. The test was performed in triplicate.
After incubation for 1 h, all samples were incubated with 1 ng/mL
lipopolysaccharide (LPS; final concentration) for another 6 h at
37◦C. The reactions were stopped by freezing the plates at−80◦C
immediately after incubation. Enzyme-linked immunosorbent
Assay (ELISA) was used to test TNFα secretion. One day prior
to ELISA testing TNFα secretion, MaxiSorp 96F-well plates
(Nunc) were coated with 2µg/mL capture antibody (eBioscience,
San Diego, CA, USA) and placed in the refrigerator overnight.
Between each step, plates were washed with Tris-buffered saline
(TBS; at pH 7.4, with 0.05% Tween-20). All incubations were at
room temperature with shaking. A volume of 200 µL blocking
buffer (TBS w/2% BSA) was added to the plates and incubated
for 1 h. Standard concentration of TNFαwere added to each plate
before incubation for 2 h. Biotin coupled anti-human antibody
(eBioscience) was diluted in assay diluent (TBS with 1% BSA) to
3 µg/mL and added to each well and incubated for 1 h. Diluted
ExtrAvidin R©-Alkaline Phosphatase (Sigma-Aldrich) was added
and plates incubated for 30min. 100 µL pNPP substrate (Sigma-
Aldrich, 1mg/mL in 1Mdiethanolamin buffer pH 9.8) was added
to each well, incubated for 45min and results read at 405 nm.
The dose-dependent response of the active extracts (10, 25, 50,
and 100 µg/mL) was further investigated. Experiments were
performed in triplicate. The pre-screening was performed using
at least two biological replicates. For the active species, biological,
and technical triplicates have been used for serial dilution testing.
Anticancer Assay
Anticancer activity was tested on the human melanoma A2058
cancer cell line [American Type Culture Collection (ATCC)
CRL-11147TM, Manassas, VA, USA]. Cell lines were seeded
in 96-well-microtitre plates (Nunc, Thermo Fisher Scientific,
United States) at 2000 cells/well in RPMI medium with 10%
fetal bovine serum (FBS) and 10 µg/mL gentamicin. Cells
were incubated for 24 h before microalgal extracts (50 µg/mL)
were added and thereafter incubated for 72 h. Cell viability was
determined by a colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay. At the end of the exposure time, 10 µl Cell Titer
96 R© Aqueous One Solution Reagent (Promega, Madison,
WI, USA) was added to each well, as for the cytotoxicity test,
and results measured after 1 h at 485 nm. The dose-dependent
response of the active extracts (10 ng/mL, 100 ng/mL, 1, 2.5,
5, 10, 12.5, 25, 50, and 100 µg/mL) was further investigated
in triplicate. The pre-screening was performed using at least
two biological replicates. For the active species, biological, and
technical triplicates have been used for serial dilution testing.
Anti-Diabetes Protein Tyrosine
Phosphatase 1B (PTP1B) Inhibition Assay
The assay was carried out in triplicate using the fluorogenic
substrate 6,8-difluoro-4-methylumbelliferyl phosphate
(DiFMUP; VWR, Leuven, Belgium) and recombinant human
PTP1B (Merck-Calbiochem, Darmstadt, Germany) as in
Ingebrigtsen et al. (2016). Microalgal extracts (50 µg/mL) were
incubated with PTP1B (1.56 ng enzyme/well) in 96-well plates.
After 30-min incubation in the dark, 25 µl of a 10 µM DiFMUP
solution were added and the fluorescent signal measured after
10min at 360 nm. The positive control was a 0.16mM solution
of PTP inhibitor IV (Merck-Calbiochem). Assay buffer was used
as the negative control. The pre-screening was performed using
at least two biological replicates.
Antibacterial Assay
The Gram-negative bacteria E. coli (ATCC 25922) and P.
aeruginosa (ATCC 27853) and the Gram-positive bacteria S.
aureus (ATCC 9144), E. faecalis (ATCC 29212), and Streptococcus
B (ATCC 12386) were used as test organisms and antibacterial
tests were performed as in Ingebrigtsen et al. (2016). The tests
were performed in 96-well-flat-bottomed plates (Nunc, Thermo
Fisher Scientific, United States), in which 50 µl of test extracts
(final concentration of 50 µg/mL, three biological replicates)
were incubated overnight at 37◦C with 50 µl of a suspension of
an actively growing (log phase) culture of bacteria. In wells where
the extracts did not have an effect on the bacteria, the bacteria
grew, and the growth media appeared opaque. In wells, where
the extracts inhibited the growth or killed the bacteria, the growth
mediumwas clear. The absorbance wasmeasured after about 20 h
at OD600 in a Victor3 Plate Reader. Bacteria plus MilliQ water
were used as positive control, while growth media plus MilliQ
water was used as negative control. Fractions were considered
active when the optical density was under 0.05.
Anti-Biofilm Assay
The biofilm-forming bacteria S. epidermidis (1% glucose was
added in the culture media to induce the biofilm formation) was
incubated with extracts at 50µg/mL overnight at 37◦C in 96 well-
plates with clear bottoms (Corning, NY, USA). For controls, no
test agents were added to the wells. Wells were carefully washed
with 100 µl PBS to eliminate free-floating bacteria. Formation
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of the bottom biofilm was fixed by incubating the plates at
65◦C for 1 h. Plates were then stained with 100 µl 0.1% crystal
violet for 10min. Excess stain was thoroughly rinsed off with
distilled water and plates were left to dry at 65◦C for at least
1 h. OD600 of stained biofilm was measured with a Victor3
Plate Reader. These optical density values were considered as
a measure of bacteria adhering to the surface and forming
biofilms and OD values under 0.25 were considered active. S.
epidermidis plus MilliQ water were used as positive control, the
control bacteria Staphylococcus haemolyticus plus MilliQ water as
negative control. Experiments were performed in triplicate. The
screening was performed using three biological replicates and
nine technical replicates.
Statistical Analysis
Statistical differences between treated and control cells for all the
assays performed in this study were determined by Student’s t-
test using GraphPad Prim statistic software, V4.00 (GraphPad
Software, San Diego, California, USA). Data were considered
significant when at least p was <0.05 (∗ for p < 0.05, ∗∗ for p
< 0.01, and ∗∗∗ for p < 0.001).
RESULTS
Cytotoxicity Assay
Toxicity tests were performed to avoid confusion between
cytotoxicity and possible bioactivity. Considering that HepG2
cells were used for <24 h in the CAA and CLPAA assays,
these cells were also used for 24 h toxicity tests. Results showed
that only Ostreopsis ovata extracts (CTRL, N- and P-starved
extracts; named FE119/1, FE119/2, and FE119/3, respectively)
were toxic and had antiproliferative activity on these liver cells
(Student’s t-test, p < 0.001), while all the other extracts did
not alter cell survival (Figure 1A, Student’s t-test, p > 0.05).
Hepatocytes are good models for studying toxicity since the liver
is the primary site for drug metabolism and biotransformation
(Gómez-Lechón et al., 2007; Nakamura et al., 2011). In order
to compare normal and cancer cells (A2058) used for the
anticancer assay, we also included a toxicity test on normal lung
fibroblast (MRC-5) cells. MRC-5 cytotoxicity test was assessed
after 72 h of extract incubations. O. ovata extracts (CTRL,
N- and P-starved extracts; FE119/1, FE119/2, and FE119/3,
respectively) were also toxic on MRC-5 cells (Student’s t-
test, p < 0.001). In addition, Alexandrium tamutum (CTRL
and P-starved extracts; FE107/1 and FE107/3, respectively),
Alexandrium minutum (CTRL and N-starved extracts; FE126
and FE126/2, respectively), Alexandrium andersoni (FE108/1,
CTRL extract) and Coscinodiscus actinocyclus (FE300/2, N-
starved extract) also showed cytotoxic activities on MRC-5 cells,
by considerably reducing cell survival (Figure 1B, Student’s t-
test, p < 0.001 for all, except p < 0.01 for FE108/1).
Antioxidant Activity (CLPAA and CAA)
Even if antioxidant biochemical assays are fast and cost-effective,
cellular assays can give more biological relevant information
since they take into account the bioavailability and metabolism
FIGURE 1 | Cytotoxicity Assay. Results from cytotoxic extracts using
HepG2 cells for 24 h (A) and MCF-7 cells for 72 h (B) compared to controls.
Results are expressed as percent survival after 24 and 72 h exposure
respectively (n = 9, data represent means for three biological and nine
technical triplicates). FE119 corresponds to Ostreopsis ovata, FE107 to
Alexandrium tamutum, FE126 to Alexandrium minutum, FE108 to Alexandrium
andersoni, and FE300 to Coscinodiscus actinocyclus (/1, /2, and /3
correspond to Normal, N-starved or P-starved extracts, respectively; ** for p <
0.01 and *** for p < 0.001, Student’s t-test).
of the tested compounds. We used two antioxidant cellular-
based assays, CAA and CLPAA, in order to assess both general
antioxidant capacity and the ability of the extracts to reduce
lipid peroxidation (CAA and CLPAA, respectively). In both
assays, O. ovata showed antioxidant properties when grown
in CTRL, N- and P-starved media (FE119/1, FE119/2, and
FE119/3, respectively). The FE119/1 showed 66% of oxidative
degeneration inhibition in the CAA assay and 74% in the CLPAA
assay, FE119/2 had 70% inhibition for the CAA and 61% for the
CLPAA, while FE119/3 showed 69% inhibition for both CAA and
CLPAA assays. In addition, alsoA. minutum (FE126/1) had 100%
antioxidant activity in the CLPAA assay. However, since both A.
minutum and O. ovata showed toxicity in the cytotoxicity assay
we did not proceed with dose-response analysis.
Anti-Inflammatory Assay
Microalgal anti-inflammatory potential was screened using
the human acute monocytic leukemia cell line (THP-1)
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and ELISA, by monitoring the release of tumor necrosis
factor α (TNFα). Species that showed TNFα inhibition
were Cylindrotheca closterium (FE2/1), Odontella mobiliensis
(FE326/1), Pseudonitzschia pseudodelicatissima (FE1098_1/1), C.
actinocyclus (FE300/2) and A. minutum (FE126/1). We found a
dose-dependent inhibition of TNFα production with increasing
concentration of C. closterium FE2/1 (Student’s t-test, p < 0.01
when tested at 10 and 25 µg/mL and p < 0.001 when tested at
50 and 100 µg/mL), O. mobiliensis FE326/1 (Student’s t-test, p <
0.01 when tested at 25µg/mL and p< 0.001 when tested at 10, 50,
and 100 µg/mL) and P. pseudodelicatissima FE1098/1 (Student’s
t-test, p < 0.01 when tested at 25 µg/mL and p < 0.001 when
tested at 50 and 100 µg/mL, Figure 2). The other active strains,
C. actinocyclus (FE300/2) and A. minutum (FE126/1), were
significantly active only when tested at 100 µg/mL (Student’s t-
test, p < 0.001), did not show a dose-response pattern and were
positive in the cytotoxicity assay. In addition, it was interesting
to note that all three diatoms, FE2/1, FE326/1, and FE1098_1/1,
were active only when grown in normal medium, and inactive
when grown in nutrient starvation conditions. This suggests that
in stressful conditions, such as nutrient starvation, these species
will not produce the compound/compounds responsible for this
activity (or they produce very low amounts). Of these three
species, C. closterium was previously shown to have antioxidant
(evaluated only by enzymatic assay, without using cells) and anti-
inflammatory properties (Affan et al., 2009). On the contrary,
no information is available regarding the bioactivities of O.
mobiliensis and P. pseudodelicatissima.
Anticancer Assay
Antiproliferative activity on human melanoma A2058 cells was
assessed for all microalgal extracts. Results showed that S.
marinoi (FE60/2), A. minutum (FE126/1), A. tamutum (FE107/1
and FE107/3) and A. andersoni (FE108/1) induced a significant
reduction in cell survival at 100 µg/mL. Successively, a dilution
series was performed and the active extracts were tested at
100, 50, 25, 12.5, 10, 2.5, and 10 ng/mL. Figure 3 shows that
S. marinoi FE60/2 inhibits cell survival in a dose-dependent
manner while for the other species, the pattern was not clear.
However, A. minutum, A. tamutum, and A. andersoni also
showed toxicity in the cytotoxicity assay. We also tested two
different S. marinoi clones, FE6 isolated in 1997 and FE60 isolated
in 2005 in the Adriatic Sea (Mediterranean Sea). Both strains
are known to produce secondary metabolites such as short-
chain polyunsaturated aldehydes (PUAs) and other oxygenated
fatty acid degradation products such as hydroxides, oxoacids,
epoxy alcohols, and hydroperoxides that induce reproductive
failure in zooplankton grazers (Miralto et al., 1999; Ianora
et al., 2004; Fontana et al., 2007; Romano et al., 2010; Gerecht
et al., 2011). PUAs isolated from FE6 have been shown to have
antiproliferative activity on colon carcinoma cells (Miralto et al.,
1999), while FE60 has never been tested before for anticancer
properties. Interestingly, extracts of FE6 did not show activity for
human melanoma cells (A2058), suggesting that the anticancer
activity was specific for a particular cancer cell line. On the other
hand, FE60 was active against A2058 cells only when grown in
nitrogen-starved medium (FE60/2) at 25, 50, and 100 µg/mL
(Student’s t-test, p < 0.05 for 25 µg/mL and p < 0.001 for 50
and 100 µg/mL), while CTRL and phosphate-starved conditions
(FE60/1 and FE60/3, respectively) were not active. These results
confirm once again that environmental conditions, such as
nutrient availability, may alter cellular metabolism, enhancing or
reducing the synthesis of the metabolites of interest.
Protein Tyrosine Phosphatase 1B (PTP1B)
Inhibition Assay
Protein thyrosine phosphatase 1B (PTP1B) is an enzyme that
is associated with the development of type 2 diabetes. PTP1B
dephosphorylates the insulin receptor and its substrates, thereby
inhibiting the effect of insulin. The potential of microalgae to
FIGURE 2 | Anti-Inflammatory Assay. Inhibition of TNFα secretion from LPS-stimulated THP-1 cells treated with extracts of Cylindrotheca closterium (FE2/1),
Odontella mobiliensis (FE326/1), Pseudonitzschia pseudodelicatissima (FE1098_1/1), Coscinodiscus actinocyclus (FE300/2), and Alexandrium minutum (FE126/1)
(n = 9, data represent means for 3 biological and 9 technical triplicates; ** for p < 0.01 and *** for p < 0.001, Student’s t-test) compared to control.
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FIGURE 3 | Anticancer Assay. Percentage viability of human melanoma cells (A2058) after incubation for 72 h with microalgal extracts (Skeletonema marinoi
FE60/2, Alexandrium andersoni FE108/1, Alexandrium tamutum FE107/1 and FE107/3, and Alexandrium minutum FE126/1) at 100, 50, 25, 12.5, 10, and 2.5 µg/mL
and 10 ng/mL (n = 9, data represent means for three biological and nine technical triplicates; * for p < 0.05, ** for p < 0.01 and *** for p < 0.001, Student’s t-test)
compared to control.
block PTP1B activity was screened, but no apparent bioactivity
was observed (data not shown).
Antibacterial Assays
Microalgal extracts were also screened against a set of bacterial
strains composed of Gram-negative bacteria E. coli and P.
aeruginosa and the Gram-positive bacteria S. aureus, E. faecalis,
and Streptococcus B. The concentration tested (50 µg/mL) was
the same as for the biofilm assay. No apparent bioactivity against
any of the tested strains was observed (data not shown), except
for FE60/2 and FE6/3 that inhibited S. aureus growth by 97
and 96%, respectively (Student’s t-test, p < 0.001 for both).
Extracts were then tested for possible inhibitory activity on
biofilm formation by the bacteria S. epidermidis. Interestingly,
two species that did not show cytotoxicity in the previous
antibacterial tests showed strong anti-biofilm formation. These
two species belong to the same microalgal genus and were
Leptocylindrus danicus (FE322) and Leptocylindrus aporus
(FE332). In particular, FE322 was able to inhibit biofilm
formation only when the alga was grown in N-starved medium
(90% Inhibition), while FE332 was active in all three culturing
conditions: CTRL (64%), N-starved (90%) and P-starved (85%)
(Student’s t-test, p < 0.001 for all conditions). For both species,
the nitrogen-starvation condition was the most active.
DISCUSSION
Our study is one of the few to simultaneously test a wide
range of marine microalgal species using the same protocols
for culturing, extraction, and testing on human cancer cell lines
and other bioactivity screenings (antioxidant, anti-inflammatory,
anti-diabetes, antibacterial, and anti-biofilm). Of the 32 species
tested (21 diatom, 7 dinoflagellate and 4 flagellate species; for
three diatoms we also tested two different clones), only diatoms
displayed bioactivity denoting the potential of this microalgal
group to produce bioactive compounds for the treatment of
human diseases. To our knowledge this is the first report on the
wide screening of marine microalgae in three different nutrient
culturing conditions for the treatment of human pathologies.
Guedes et al. (2013) tested the antioxidant capacity of 23
microalgae (P. tricornutum was the only diatom) cultured in
only one growth condition, Samarakoon et al. (2013) tested
the anti-inflammatory (nitric oxide production inhibition) and
anticancer (i.e., on human promyelocytic leukemia cell line
HL60, mouse melanoma cell line B16F10 and human lung
carcinoma cell line A549) activity for one diatom and one
dinoflagellate cultured in only one growth condition, Shah
et al. (2014) tested the antioxidant (DPPH radical scavenging
assay), anti-inflammatory (nitric oxide production inhibition)
and anticancer (human promyelocytic leukemia cell line HL-60)
activities of 11 benthic dinoflagellates collected in Jeju Island
(Korea), cultured in two different culture media (IMK and f/2
medium). Finally, Ingebrigtsen et al. (2016) tested the bioactivity
(for antioxidant, antibacterial, anti-inflammatory, anti-diabetes,
and anticancer) of five North-Atlantic diatoms grown in four
different light/temperature conditions. In addition to these broad
screenings, there are a few other studies on the activity of
single species, such as the anticancer activity of the diatom
Chaetoceros calcitrans (strain UPMAAHU10) on human breast
cell line MCF-7 (Nigjeh et al., 2013), the anticancer effect
of Dunaliella salina (green microalgae, strain from Iran) on
skin carcinoma cell line A431 (Emtyazjoo et al., 2012), the
anticancer activity of amphidinolides H and N, isolated from the
dinoflagellate A. carterae, on human tumor cell lines (Kobayashi,
2008) and beneficial effects in a transgenic mouse model of
Alzheimer’s disease (Alonso et al., 2013) inferred by 13-desmethyl
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spirolide C (polyketide-derived), synthetized by the dinoflagellate
A. ostenfeldii (MacKinnon et al., 2006).
In the current study, of the 32 species tested three
showed anti-inflammatory properties (C. closterium FE2/1, O.
mobiliensis FE326/1, and P. pseudodelicatissima FE1098_1/1),
one species had anticancer activity (S. marinoi FE60/2), two
species showed antibacterial properties (S. marinoi FE60/2 and
S. marinoi FE6/3) and another two blocked bacteria biofilm
formation (L. danicus FE322/2, L. aporus FE332/1, FE332/2,
and FE332/3) (see Summary in Figure 4). Inflammation is a
protective response that involves immune cells, blood vessels,
and different molecular mediators (e.g., TNFα, IL1, nitric
oxide, and prostaglandins). Anti-inflammatory properties were
previously found for other microalgae, such as the green algae
Dunaliella bardawil (Lee et al., 2013), the diatoms Porosira
glacialis, Attleya longicornis (Ingebrigtsen et al., 2016), and P.
tricornutum (Samarakoon et al., 2013), and the dinoflagellate
A. carterae (Samarakoon et al., 2013). Here we evaluated
the anti-inflammatory potential of 32 species analyzing the
capacity of the microalgal extracts to inhibit TNFα release
in LPS-treated acute monocytic leukemia THP-1 cells and
we found activity for three diatoms C. closterium FE2/1, O.
mobiliensis FE326/1, and P. pseudodelicatissima FE1098_1/1.
Ingebrigtsen et al. (2016) used the same protocol and found
activity for the North-Atlantic diatoms P. glacialis and A.
longicornis. Interestingly, C. closterium FE2/1, O. mobiliensis
FE326/1, and P. pseudodelicatissima FE1098_1/1 were active
only when grown in normal medium, and inactive when
grown in nutrient starvation conditions (i.e., nitrogen- and
phosphate-starved media) suggesting that in stressful conditions,
such as nutrient starvation, these species will not produce
the compound/compounds responsible for this activity (or
they produce very low amounts). This is in contrast to other
secondary metabolites produced by diatoms such as PUAs and
domoic acid (DA), that are produced in higher quantities
under stress conditions, i.e., aging and nutrient starvation
conditions (Maldonado et al., 2002; Fehling et al., 2004 Ribalet
et al., 2007; Martin-Jézéquel et al., 2015). Similarly, Fehling
et al. (2004) found an increased production of DA when
Pseudo-nitzschia seriata (Cleve) was cultured under silicate-
limitation, while Martin-Jézéquel et al. (2015) found higher
toxin content in nitrogen-starvation conditions for Pseudo-
nitzschia multiseriesCCL70 and Pseudo-nitzschia australis PNC1.
In addition, Maldonado et al. (2002) observed an increased DA
production for both P. multiseries and P. australis in Fe-deficient
and Cu-stressed conditions.
The diatom S. marinoi showed very interesting results in
the current study. One clone of this species S. marinoi (FE60)
showed anticancer activity on human melanoma A2058 cells,
but only when cultured in nitrogen-starvation conditions. The
other clone FE6 was not active against cancer cells. In addition,
both clones (S. marinoi FE60 and FE6) showed antibacterial
properties by inhibiting the survival of S. aureus. However, FE60
had antibacterial properties only when cultured in nitrogen-
starvation conditions, while FE6 only in phosphate-starvation
condition. These data indicated clone-specific differences in
FIGURE 4 | Summary chart. Summary of the species and culturing conditions (CTRL, nitrogen- and phosphate-starved media, indicated with N- and P-starv.
medium, respectively) that showed anti-inflammatory (Cylindrotheca closterium FE2/1, Odontella mobiliensis FE326/1, Pseudonitzschia pseudodelicatissima
FE1098_1/1), anticancer (Skeletonema marinoi FE60/2), and anti-biofilm properties (Leptocylindrus danicus FE322/2 and Leptocylindrus aporus FE332/1, FE332/2,
and FE332/3). In addition, approximate cell concentration used for the preparation of the chemical extracts tested and species photos are reported.
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biological activity, but both were active when cultured under
nutrient-starvation.
To our knowledge, this is the first report of so many diatoms
(and microalgae in general) tested on human melanoma A2058
cells. Ingebrigtsen et al. (2016) were the only authors to test
a clone of S. marinoi against this extremely malignant cancer
cell line. They tested a North Atlantic clone and found that
this clone had antiproliferative activities on A2058 cells only
when cultured at low temperature-high light, while it was not
active in other culturing conditions. In addition, their clone
was not active against bacteria. S. marinoi, as other diatoms,
are known to produce a series of secondary metabolites (PUAs
and other oxylipins) with anticancer properties (Miralto et al.,
1999; Sansone et al., 2014). Considering that all S. marinoi
clones produce oxylipins, even if in different amounts (Gerecht
et al., 2011), we suggest that the compounds responsible for the
observed anticancer and antibacterial activities are not oxylipins
because only one clone has anticancer activity. Taking into
account that in this study the resin Amberlite (which binds
non-polar solutes in the microalgal extract, Sigma-Aldrich) was
used for the pre-fractionation, we suggest that other non-polar
compounds may be responsible for the observed bioactivities.
This is the first time that anti-biofilm activity is reported
for microalgae (activity against the biofilm-forming bacteria
S. epidermidis). Of the 32 species tested, the two species L.
danicus (FE322) and L. aporus (FE332), belonging to the
same microalgal genus, showed strong anti-biofilm activity. In
particular, FE322 was able to inhibit biofilm formation only
when the alga was grown in N-starved medium (90% Inhibition),
while FE332 was active in all three culturing conditions:
CTRL (64%), N-starved (90%), and P-starved (85%). For both
species, the nitrogen-starvation condition was the most active,
indicating that this stress condition increased the production
of the compound/compounds responsible for this activity. S.
epidermidis is a permanent and ubiquitous colonizer of human
skin. Treatment is complicated by specific antibiotic resistance
genes and the formation of biofilms, multicellular agglomerations
that have intrinsic resistance to antibiotics (Otto, 2009). S.
epidermidis infections have gained increasing attention because
they represent the most common source of hospital-acquired
infections (Levinson, 2010) and are of particular concern for
people with catheters or other surgical indwelling medical
devices (Salyers and Whitt, 2002). The discovery that microalgae
possess anti-biofilm activity against this bacterium opens new
possibilities for the treatment of S. epidermidis infections. Future
chemical investigations may allow the identification of the
compounds responsible of the reported activities.
In conclusion, the results reported in this study show
the absence of correlations between bioactivity and a specific
microalgal class or a specific culturing condition. When the
culturing parameters are modified, the same organism may show
different bioactivities and produce diverse metabolites (Bode
et al., 2002). This strategy, termed OSMAC (One strain–many
compounds), has successfully been applied for biodiscovery
in bacteria (Bode et al., 2002) and could potentially also
work in microalgae. The production of primary and secondary
metabolites in microalgae can vary depending on e.g., growth
phases (Vidoudez and Pohnert, 2012), clones (Gerecht et al.,
2011), light (Depauw et al., 2012), temperature (Huseby et al.,
2013), culturing media (Alkhamis and Qin, 2015), grazing
pressure (Pohnert, 2002), extraction method (Jüttner, 2001), and
probably many other factors (Chen et al., 2011). This metabolic
plasticity positively influences drug discovery by triggering
bioactivities and hopefully leading to the discovery of novel
bioactive compounds for the treatment of human diseases.
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